Clinical Trials Logo

Gingival Diseases clinical trials

View clinical trials related to Gingival Diseases.

Filter by:

NCT ID: NCT02523326 Recruiting - Clinical trials for Periodontal Disease Unrecognized Condition

Design of a Protocol for Obtaining Genomic DNA From Saliva

DPOGDNAS
Start date: February 2015
Phase: N/A
Study type: Observational

Objective The aim of this study was to test a protocol for the extraction of high quality genomic DNA from saliva samples obtained with mouthwash and taken from patients with periodontal disease. Materials and methods Saliva samples were taken from 60 patients, then stored at room temperature. DNA extraction was carried out at distinct post-sampling times (10, 20 and 30 days). Evaluation of genomic DNA was performed with spectrophotometry, electrophoresis, and PCR genotyping and sequencing.

NCT ID: NCT02352038 Recruiting - Periodontal Disease Clinical Trials

Randomized Controlled Trial of a Novel Laser-aided Orthodontic-periodontal Treatment Strategy

Start date: April 2014
Phase: N/A
Study type: Interventional

The aim of the study is to assess the effects of low-level laser therapy (LLLT) in patients with periodontitis during orthodontic-periodontal treatment for 12 months on the following aspects: (1) Effects on periodontal status; (2) Effects on alveolar bone remodeling; (3) Effects on cervical dentin sensitivity; (4) Effects on pain and quality of life. To eliminate any bias, the investigators will initially hypothesize that there is no difference in periodontal status, jawbone remodeling, tooth sensitivity, pain and quality of life in patients having teeth with chronic periodontitis and receiving LLLT with orthodontic treatment versus teeth undergoing orthodontic treatment without incorporation of LLLT.

NCT ID: NCT01405365 Recruiting - Obesity Clinical Trials

The Impact of Obesity on Nonsurgical Periodontal Therapy

Start date: August 2009
Phase: N/A
Study type: Interventional

The purpose of this study is to investigate the effect that obesity may have on the nonsurgical treatment (with and without the adjunct use of metronidazole) of destructive periodontal diseases (chronic periodontitis).

NCT ID: NCT00553007 Recruiting - Metabolic Syndrome Clinical Trials

The Relation Between Periodontal Disease and Metabolic Syndrome

Start date: October 2007
Phase: N/A
Study type: Interventional

Periodontal disease is associated with the components of Metabolic syndrome, such as obesity, diabetes, hypertension and hyperlipidemia. Therefore, strong relation with periodontal disease and metabolic syndrome is suggested. the overall goal of this study is to define the relation between periodontal disease and metabolic syndrome, including atherosclerosis.

NCT ID: NCT00162838 Recruiting - Periodontal Disease Clinical Trials

Effects of Periodontal Pathogens, Porphyromonas Gingivalis and Tannerella Forsythensis, on Cytokine Production From Human Monocyte-Derived Dendritic Cells

Start date: October 2003
Phase: N/A
Study type: Observational

Periodontitis develops due to subgingival infection with specific microbial pathogen from dental plaque. The bacteria can activate immunoinflammatory mechanisms within the local periodontal tissues that lead to destruction of collagen and alveolar bone. Human gingiva contains Langerhans and connective tissue dendritic cells. Signals from periodontal pathogen can induce dendritic cells to maturation,rapidly increasing surface expression of MHC class II, costimulatory molecules, and secrete proinflammatory cytokines to regulate adaptive T cell immune response. Studies on cytokines have led to controversy about different T cell subsets associated with the progression of periodontitis. Seymour proposed that susceptibility to periodontal disease progression involve a predominantly Th2 response while Ebersole speculated that Th2 cells providing protective function. It is possible that a given pathogen may produce different maturation signals by activating DCs induce a given type of immune response. In this study, we observed the profiles and amounts of cytokine production of DCs stimulated with P. gingivalis and T. forsythensis compared with E. coli, to see whether the periodontal pathogens may induce different response of dendritic cells in the innate immunity.

NCT ID: NCT00064766 Recruiting - Periodontal Disease Clinical Trials

Norplant and Irregular Bleeding/Spotting

Start date: February 2003
Phase: Phase 4
Study type: Interventional

Irregular or prolonged menstrual bleeding and/or spotting are common side effects in patients using progestin-only hormonal contraception such as levonorgestrel implants (Norplant). Doxycycline, a drug approved by the Food and Drug Administration (FDA) to treat gum disease, may reduce the occurrence of uterine bleeding and spotting in women who use Norplant. This study will evaluate the effects of doxycycline on uterine bleeding/spotting in women using Norplant.